Respiratory Flashcards
Pathophysiology of asthma
Chronic inflammation (due to IgE release from mast cells) of the airways causing episodic bronchoconstriction leading to reversible airflow limitation.
Describe the chronic remodelling/histological changes of airways seen in asthma
Thickening of sub-basement membrane
sub epithelial fibrosis
airways smooth muscle hypertrophy + hyperplasia
Mucus gland hyperplasia + hyper secretion
Common triggers in asthma
Cold air
Exercise
NSAIDs / Aspirin
Beta-blockers
Infection
Animals
Dust
Moulds
Clinical Features of asthma
Episodic symptoms + Diurnal variation
Bilateral widespread polyphonic wheeze
Dry cough
History of atopy / exposure to trigger
1st line investigations for asthma
Fractional exhaled NO + Spirometry
>40 parts NO is diagnostic + spirometry must demonstrate 12% increase in FEV1 or PEFR following bronchodilator use
2nd line investigations for asthma
PEFR diary or Bronchial provocation test
Management of Asthma (Age >12yrs)
- SABA prn
- SABA + low dose ICS
- SABA + low dose ICS + LTRA
- SABA + low dose ICS + LABA (+/- LTRA if helped)
- SABA + MART (ics + laba)
- SABA + Med dose ICS + LABA
- Refer - for consideration of high dose ICS or adding in Theophylline/Aminophylline
MOA and Example of LTRA
Montelukast
MOA = Leukotreine antagonist. reduces inflammation, bronchoconstriction and mucus secretions.
What monitoring is needed for theophylline
Plasma levels 5 days after initiation and 3 days after each dose change (due to low therapeutic index)
Definition of COPD
Progressive, irreversible long term airflow obstruction caused by damage to lung tissue.
What are the 2 conditions outlined by COPD
Emphysema + Chronic Bronchitis
RF for COPD
Smoking
Age
FHx
A1AT deficiency
Exposure to dust
Sulphur dioxide exposure
Histological changes in COPD
Narrowing of airways
Airways remodelling (pseudo stratified columnar epithelium –> Squamous cell)
Increased number of goblet cells
Mucus gland hyperplasia
Vascular bed changes –> Pulmonary HTN
What is emphysema?
Enlargement of alveolar airspace due to breakdown of elastin and destruction of alveolor walls leading to loss of lung elastic recoil + small airways collapse resulting in air trapping.
What is chronic bronchitis
Chronic productive cough due to goblet cell hyperplasia and fibrosis + thickening of airways resulting in airflow limitation
How to differentiate between Emphysema + Chronic bronchitis subtypes
Emphysema = ‘Pink puffers’ - barrel chest, SOB, pursed lip breathing, weight loss, accessory muscle use
Bronchitis = ‘Blue bloaters’ - chronic cough, ascites, ankle oedema, cor pulmonale, cyanosis, polycythemia
Clinical Signs of COPD
Hypoxemia
Asterixes
Distant breath sounds
Tachypnoea
R sided HF signs
MRC dyspnoea scale
1 = Breathless on strenuous exercise
2 = Breathless on walking uphill
3 = Breathless that slows on walking flat
4 = Needs to stop + catch breath after walking 100m on flat
5 = unable to leave house due to SOB
Investigations for COPD
Clinical Features + Spirometry (Obstructive pattern reduced FEV1:FVC)
Classification of COPD severity
Mild = FEV1 >80%
Moderate = FEV1 50-79%
Severe = FEV 30-49%
Very severe = FEV1 <30%
CXR findings in COPD
Lung hyperinflation, bullae, flattened diaphragm
Special tests in suspected COP
Echocardiogram + ECG (if suspecting cor pulmonale)
TLCO = decreased
Genetic testing (for A1AT deficiency)
Management pathway for COPD
- SABA or SAMA (e.g ipratropium)
- If steroid responsive/asthma features = LABA +ICS
- If not steroid responsive = LABA + LAMA (make sure to stop SAMA)
- LABA + LAMA + ICS
- Add theophylline / azithromycin / Carbocystine
- Consider LTOT or lung volume reduction surgery
What monitoring is needed prior to azithromycin treatment
LFTs
ECG - can cause prolonged QT interval (tdp)
Indications for long term oxygen therapy in COPD patients
2 ABGs at least 3 weeks apart showing SpO2 < 7.3
FEV1 <30%
Polycythemia
Peripheral oedema
Raised JVP
Sp02 < 92% on air
Which condition is characterised by Bronchiectasis + emphysema + Liver cirrhosis
Alpha-1 Antitrypsin deficiency
What is the inheritance of A1AT deficiency
Autosomal recessive mutation to the SERPINA1 gene on chromosome 14
Which type of lung cancer is most common
NSCLC - Squamous cell
Which type of lung cancer has the strongest associated with smoking?
Squamous cell
Which type of lung cancer is most common in non-smokers
Adenocarcinoma
Which type of lung cancer originates in neuroendocrine cells - APUD/Kulchitsky cells?
SCLC
Which lung cancer is caused by undifferentiated tumour cells?
Large cell
Cavitating lesions with central necrosis on CXR is indicative of which type of lung cancer?
Squamous cell
What are the paraneoplastic extramanifestations of pancoast tumours
- Recurrent laryngeal nerve palsy
- Phrenic nerve palsy
- SVC obstruction
- Brachial plexus palsy
- Horner’s syndrome
Signs + Symptoms of SVC obstruction
Facial swelling
SOB
Distended neck veins
Pemberton’s sign - facial congestion + cyanosis when hands raised above head
Hypercalcemia, Hyperthyroidism and Hypertrophic pulmonary osteoarthropathy are parenoplastic manifestations of which type of lung cancer?
Squamous cell carcinoma
Gynaecomastia is associated with which type of lung cancer?
adenocarcinoma
What are the paraneoplastic manifestations associated with SCLC?
- SIADH
- Cushing’s
- Hypercalcemia
- Lambert-eaton syndrome
- Limbic encephalitis
Management of SCLC
Radiotherapy + Chemotherapy
Management for NSCLC
Surgery (Lobectomy) + neoadjuvant chemotherapy
Contraindications to surgery in Squamous cell lung cancer
Stage IIIb or IV
FEV1 <1.5
Malignant pleural effusion
Tumour near the hilum
Vocal cord paralysis
SVC obstruction
Clinical Features of mesothelioma
History of asbestos exposure
SOB
chest pain
SOB
Clubbing
Painless pleural effusion
1st line investigation for mesothelioma
CXR: shows pleural effusion / pleural thickening / pleural plaques
Next step = Pleural CT and consider a pleural aspirate if effusion is present
Most common cause of pneumonia in general population
Streptococcus pneumoniae
Most common cause of pneumonia in COPD patients
Haemophilius influenzae
Main cause of Hospital acquired pneumonia
Staph aureus
Which patients tend to get Morazella catarrhalis pneumonia?
Immunocompromised patients or those with chronic lung diseases